Current NDC auxiliary source row compounder:4564

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 70713-101
Product Ndc: 70713-101
Product Ndc Digits: 70713101
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: BENZOCAINE LIDOCAINE TETRACAINE 20 6 4
Proprietary Name Suffix: [empty]
Nonproprietary Name: BENZOCAINE LIDOCAINE TETRACAINE 20 6 4
Dosage Form Name: CREAM
Route Name: TRANSDERMAL
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Wells Pharmacy, Inc
Establishment Name: Wells Pharmacy, Inc
Establishment Fei: [empty]
Substance Name: TETRACAINE; BENZOCAINE; LIDOCAINE
Active Ingredients Info: 40 mg/1 mL; 200 mg/1 mL; 60 g/1 mL
History Active Ingredients Raw: TETRACAINE; BENZOCAINE; LIDOCAINE
History Active Ingredients Info Raw: 40 mg/1 mL; 200 mg/1 mL; 60 g/1 mL
History Dosage Raw: CREAM
Dea Schedule: [empty]
Package Ndc Raw: 70713-101-01
Package Ndc: 70713-101-01
Package Ndc Digits: 7071310101
Package Ndc11: 70713010101
Package Description: 120 mL in 1 BOTTLE, PUMP (70713-101-01)
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:4564
Source Row Number: 4564
Source Row Hash: 309c042bf04bd00db8910e54c369abada51a01f43679a286151ffd7a89d5546d
Import Run Id: 20261026T055812Z
Loaded At: 2026-10-26 06:02:33

Exact raw FDA source fields#

{
    "ROUTENAME": "TRANSDERMAL",
    "PRODUCTNDC": "70713-101",
    "DEASCHEDULE": "",
    "LABELERNAME": "Wells Pharmacy, Inc",
    "SUBSTANCENAME": "TETRACAINE; BENZOCAINE; LIDOCAINE",
    "DOSAGEFORMNAME": "CREAM",
    "NDCPACKAGECODE": "70713-101-01",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "BENZOCAINE LIDOCAINE TETRACAINE 20 6 4",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "BENZOCAINE LIDOCAINE TETRACAINE 20 6 4",
    "PACKAGEDESCRIPTION": "120 mL in 1 BOTTLE, PUMP (70713-101-01) ",
    "ACTIVEINGREDIENTSINFO": "40 mg/1 mL; 200 mg/1 mL; 60 g/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:4564
Source Row Number: 4564
Status Scope: package
Lookup Ndc: 70713-101-01
Lookup Ndc Digits: 7071310101
Product Ndc: 70713-101
Product Ndc Digits: 70713101
Package Ndc: 70713-101-01
Package Ndc Digits: 7071310101
Package Ndc11: 70713010101
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 309c042bf04bd00db8910e54c369abada51a01f43679a286151ffd7a89d5546d
Import Run Id: 20261026T055812Z
Loaded At: 2026-10-26 06:02:33